Janux Therapeutics, Inc. (JANX)
13.84
-0.13
(-0.93%)
USD |
NASDAQ |
Mar 06, 16:00
14.00
+0.16
(+1.16%)
After-Hours: 20:00
Janux Therapeutics Cash from Investing (TTM) : -300.98M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Bristol Myers Squibb Co. | -4.132B |
| MannKind Corp. | -304.80M |
| EyePoint Plc | -- |
| Madrigal Pharmaceuticals, Inc. | 32.32M |
| CorMedix, Inc. | -- |